T-cell activation and fibroblastic BMP4-Gremlin dysregulation indicate disease severity in acute myocarditis
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Abstract Background and Aims Acute myocarditis (AM) is a T cell-mediated myocardial disease with clinical manifestations ranging from mild chest pain to cardiogenic shock. Reliable biomarkers to stratify patients and guide therapy are currently lacking. In particular, the extent of the dysregulation of inflammatory pathways, and the impact on myocardial dysfunction, remain elusive. Methods Serum analyses were performed in prospectively recruited AM patients (n = 103) from two independent cohorts. Multimodal data integration combining profiling of cytokine and chemokine dysregulation with clinical biomarkers was used to define clinical phenotypes with distinct inflammatory signatures. Machine-learning and regression models were applied to determine biomarkers that indicate clinical severity. Results Immuno-proteomic profiling revealed conserved inflammatory patterns across AM cohorts, dominated by T cell-related cytokines and chemokines. In addition, AM patients showed dysregulation of fibroblast-derived cytokines, including hepatocyte growth factor (HGF), bone morphogenic protein 4 (BMP4) and the BMP4 inhibitors Gremlin-1 (GREM1) and Gremlin-2 (GREM2). Data integration and unsupervised clustering revealed two immuno-clinical phenotypes, linking T cell activation and fibroblast dysregulation to disease severity. Machine learning-based analysis identified CXCL10, GREM2 and LVEF as critical parameters for stratifying disease severity. Conclusions These findings highlight a systemic T cell activation signature as diagnostic hallmark of AM. In addition, dysregulation of fibroblast-derived tissue cytokines serves as an indicator for distinct immuno-clinical phenotypes in myocardial inflammatory disease. Thus, the clinically relevant link between T cell-driven immune activation, myocardial inflammation and fibroblast-driven remodelling provides a versatile set of parameters to identify severe manifestations of AM. Graphical Abstract Key Question: Are serological immune signatures linked to clinical severity in acute myocarditis and do they enable patient stratification? Key Findings: T cell- and fibroblast associated proteomic signatures indicate disease severity in acute myocarditis. Novel immuno-clinical phenotypes stratify patients according to distinct immune responses and clinical manifestations. CXCL10, GREM2 and LVEF are the most important parameters to identify immuno-clinical phenotypes. Take Home Message: CXCL10, GREM2 and LVEF emerge as key determinants for a severe immuno-clinical phenotype in acute myocarditis, highlighting the role of T cell-fibroblast interaction in the disease process and linking T cell activation, fibroblastic tissue remodelling and impaired cardiac function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308
Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation
Ferreira, V. M., Schulz-Menger, J., Holmvang, G., Kramer, C. M., Carbone, I., Sechtem, U., Kindermann, I., Gutberlet, M., Cooper, L. T., Liu, P., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.072 · Cited by 2,059
Self-citationMarcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., Calkins, H., Corrado, D., Cox, M. G. P. J., Daubert, J. P., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq025 · Cited by 1,612
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.963 · Cited by 1,193
Dufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E., & Luster, A. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3195 · Cited by 1,075
Missing Data in Clinical Research: A Tutorial on Multiple Imputation
Austin, P. C., White, I. R., Lee, D. S., & van Buuren, S. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.11.010 · Cited by 1,006
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
Moslehi, J. J., Salem, J.-E., Sosman, J. A., Lebrun-Vignes, B., & Johnson, D. B. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30533-6 · Cited by 942
The spectrum of inflammatory responses
Medzhitov, R. (2021) · Science · doi:10.1126/science.abi5200 · Cited by 718
Fibroblasts as immune regulators in infection, inflammation and cancer
Davidson, S., Coles, M., Thomas, T., Kollias, G., Ludewig, B., Turley, S., Brenner, M., & Buckley, C. D. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00540-z · Cited by 605
Self-citationAmmirati, E., Cipriani, M., Moro, C., Raineri, C., Pini, D., Sormani, P., Mantovani, R., Varrenti, M., Pedrotti, P., Conca, C., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035319 · Cited by 452
Cited by
Myocardial Immune Niches in Homeostasis and Inflammation
Perez‐Shibayama, C., Cadosch, N., Schmidt, D., Flammer, A. J., Ruschitzka, F. T., Gil‐Cruz, C., & Ludewig, B. (2026) · Immunological Reviews · doi:10.1111/imr.70139 · Cited by 4
“The BMP4-GREM axis may therefore function as a stromal rheostat regulating the balance between reparative adaptation and chronic inflammatory remodeling within myocardial niches [44, 149].”
Self-citation
Metadata
- Authors
- Joachimbauer, A., Perez-Shibayama, C., Payne, E., Hanka, I., Stadler, R., Papadopoulou, I., Rickli, H., Mäder, M. T., Borst, O., Zdanyte, M., Cooper, L., Flatz, L., Matter, C. M., Wilzeck, V. C., Manka, R., Saguner, A. M., Ruschitzka, F., Schmidt, D., Ludewig, B., & Gil-Cruz, C.
- Affiliations
- Kantonsspital St. Gallen (CH)
- Institute of Immunobiology, Medical Research Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
- Department of Cardiology, Cantonal Hospital St. Gallen, St. Gallen
- University of Tübingen (DE)
- DFG Heisenberg Group Cardiovascular Thromboinflammation and Translational Thrombocardiology, University of Tübingen, Germany
- Mayo Clinic (US)
- University of Zurich (CH)
- ETH Zurich (CH)
- Department of Cardiology, University Hospital Zürich
- Corresponding author
- Ludewig, Burkhard
- ORCID
- Venue
- medRxiv
- Publisher
- openRxiv
- Published
- 2026-04-11
- OpenAlex
- W7153577213
- Cited by
- 1
- References
- 50
- Citations by year
- 2026: 1
- Type
- posted content
- Language
- en
- Open access
- closed
- Locations
- medRxiv (acceptedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Takotsubo Cardiomyopathy and Associated Phenomena
- Keywords
- acute myocarditis, T cell activation, BMP4, GREM1, hepatocyte growth factor, CXCL10, disease severity markers, patient stratification, myocarditis, left ventricular ejection fraction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: T-cell activation and fibroblastic BMP4-Gremlin dysregulation indicate disease severity in acute myocarditis. https://app.cochat.ai/papers/10.64898/2026.04.10.26350598
- The paper
- Joachimbauer, A., Perez-Shibayama, C., Payne, E., Hanka, I., Stadler, R., Papadopoulou, I., Rickli, H., Mäder, M. T., Borst, O., Zdanyte, M., Cooper, L., Flatz, L., Matter, C. M., Wilzeck, V. C., Manka, R., Saguner, A. M., Ruschitzka, F., Schmidt, D., Ludewig, B., & Gil-Cruz, C. (2026). T-cell activation and fibroblastic BMP4-Gremlin dysregulation indicate disease severity in acute myocarditis. medRxiv. https://doi.org/10.64898/2026.04.10.26350598
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.